查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1722460

2025 年至 2033 年兽医分子诊断市场报告（按产品、技术、动物类型、疾病类型、最终用户和地区）

Veterinary Molecular Diagnostics Market Report by Product, Technology, Animal Type, Disease Type, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球兽医分子诊断市场规模达 7.456 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 14.822 亿美元，2025-2033 年期间的成长率 (CAGR) 为 7.54%。推动市场成长的主要因素包括：越来越多的人开始饲养宠物，分子诊断技术不断进步，以及为规范兽医实践中的分子诊断测试而不断实施严格的监管指南和品质控制标准。

兽医分子诊断市场分析：

  • 主要市场驱动因素：宠物拥有量的增加是推动市场成长的重要因素之一。此外，对能够快速准确地检测动物传染源的分子诊断的需求不断增长，有助于防止疾病传播给人类并保障公众健康，从而推动市场的成长。
  • 主要市场趋势：个人化医疗在兽医护理中的应用日益广泛，以製定治疗计划并预测疾病易感性，为整个市场创造了积极的前景。
  • 竞争格局：一些领先的兽医分子诊断公司包括 Biochek BV、bioMerieux SA、HealthGene Corporation、Heska Corporation、IDEXX Laboratories Inc.、INDICAL BIOSCIENCE GmbH、Ingenetix GmbH、NEOGEN Corporation、Qiagen NV、Thermo Fisher Scientific Inc.、Veterile
  • 地理趋势：根据报告，北美占据最大的市场份额。这可以归因于越来越多的人养宠物来享受宠物的陪伴。除此之外，分子诊断测试的价格越来越便宜，使其成为更广泛的兽医实践的可行选择，从而促进了市场的成长。
  • 挑战与机会：兽医分子诊断的挑战包括需要具有成本效益和用户友好的技术，以及需要广泛的验证以确保不同动物物种的准确性。机会在于开发快速的即时诊断检测方法，以及根据遗传资讯制定个人化治疗计划的潜力，从而推动动物保健的发展。

兽医分子诊断市场趋势：

养宠物的人数日益增多

越来越多的人开始饲养宠物，这对兽医分子诊断市场产生了积极的影响。宠物拥有量的激增导致对兽医服务（包括诊断）的需求增加。例如，根据英国宠物食品製造商协会2021年3月发布的宠物数量资料，英国超过59%的家庭拥有宠物，2021年宠物数量超过3,260万隻。将宠物视为家庭成员的趋势日益增长，这反过来又增加了兽医分子诊断市场的需求。此外，狗和猫是宠物主人最爱的宠物。例如，2022 年狗的数量约为 6.045 亿隻，而猫的数量约为。全球有4.082亿。此外，美国宠物产品协会于2022年4月发布报告称，2021年美国宠物产业总支出达1,236亿美元，高于2020年的1,036亿美元。动物保健支出的成长预计将推动兽医分子诊断市场的成长，因为预计相当一部分宠物主人将使用先进的诊断方式来治疗动物的各种疾病，并推动兽医分子诊断市场近期的价格上涨。

动物疾病发生率上升

动物疾病发生率的上升促进了兽医分子诊断市场的成长。卡加利大学于 2021 年 6 月发表的一项研究旨在调查家犬感染多房棘球绦虫的情况，以推断其在人畜共患病传播中的潜在作用，该研究表明，多房棘球绦虫是北半球（加拿大艾伯塔省）的一种寄生蠕虫，通常会在终宿主和中间宿主之间循环。但在城市地区，家犬也可能成为这种寄生虫的宿主，由于它们距离较近，可能对人类构成重大风险因素。此外，据估计，每年有五分之一的农场动物因疾病而死亡，而更多的动物则遭受疾病的影响。根据新兴病原体研究所 2021 年 11 月发表的一篇文章，牛呼吸道疾病占饲养场疾病的 75%，每年对养牛户造成的经济损失超过 10 亿美元。红眼症每年造成的损失估计为 1.5 亿美元，而腐蹄病对乳製品生产商造成的损失为每头乳牛 120 至 350 美元。预计动物损失和遗传疾病的增加将推动对兽医分子诊断的需求，从而增加兽医分子诊断的市场份额。

分子诊断技术的不断进步

分子诊断技术的不断进步正在促进市场的成长。聚合酶炼式反应 (PCR)、次世代定序 (NGS) 和微阵列分析等尖端分子诊断技术正在不断发展，为兽医提供有关动物健康的无与伦比的见解。此外，各主要市场参与者正在推出改良的诊断试剂盒和仪器，以促进高品质的诊断和治疗。例如，2022 年 4 月，格林斯伯勒的 Carolina Liquid Chemistries Corp 签署了一项半独家协议，为美国兽医市场分销便携式分析仪。该公司分销的 SeamatySMT-120 VP 兽医自动化学分析仪，是一款用于动物健康诊断的紧凑型全自动化学、电解质免疫分析和凝血分析仪。同样，2021 年 9 月，Micro Vet Diagnostics 推出了 Micro-chem II，这是一款用于动物健康的全新化学、电解质、免疫分析和凝血分析仪，可提供准确的参考和实验室品质的结果。这些创新提高了兽医实验室的效率，并缩短了测试结果的周转时间，预计将在未来几年推动兽医分子诊断市场的收入。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球兽医分子诊断市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 试剂盒和试剂
  • 仪器
  • 软体和服务

第七章：市场区隔：依技术

  • 实时PCR
  • 微阵列
  • DNA定序

第八章：市场区隔：依动物类型

  • 伴侣动物
  • 牲畜

第九章：市场细分：依疾病类型

  • 媒介传播疾病
  • 呼吸道病原体
  • 腹泻病原体
  • 其他的

第十章：市场区隔：依最终用户

  • 兽医院
  • 临床实验室
  • 研究机构

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第 16 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Biochek BV
    • bioMerieux SA
    • HealthGene Corporation
    • Heska Corporation
    • IDEXX Laboratories Inc.
    • INDICAL BIOSCIENCE GmbH
    • Ingenetix GmbH
    • NEOGEN Corporation
    • Qiagen NV
    • Thermo Fisher Scientific Inc.
    • Veterinary Molecular Diagnostics Inc.
    • Zoetis Inc.
Product Code: SR112025A5121

The global veterinary molecular diagnostics market size reached USD 745.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,482.2 Million by 2033, exhibiting a growth rate (CAGR) of 7.54% during 2025-2033. The growing adoption of pets among the masses, increasing advancements in molecular diagnostic technologies, and rising implementation of stringent regulatory guidelines and quality control standards to standardize molecular diagnostic tests in veterinary practice are some of the major factors propelling the market growth.

Veterinary Molecular Diagnostics Market Analysis:

  • Major Market Drivers: Increasing pet ownership is one of the significant factors driving the growth of the market. Additionally, the rising demand for molecular diagnostics that can rapidly and accurately detect infectious agents in animals, helping to prevent disease transmission to humans and safeguard public health, is impelling the growth of the market.
  • Key Market Trends: The rising utilization of personalized medicine in veterinary care to tailor treatment plans and predict disease susceptibility is creating a positive outlook for the overall market.
  • Competitive Landscape: Some of the leading veterinary molecular diagnostics companies include Biochek B.V., bioMerieux SA, HealthGene Corporation, Heska Corporation, IDEXX Laboratories Inc., INDICAL BIOSCIENCE GmbH, Ingenetix GmbH, NEOGEN Corporation, Qiagen N.V, Thermo Fisher Scientific Inc., Veterinary Molecular Diagnostics Inc., and Zoetis Inc., among others.
  • Geographical Trends: According to the report, North America accounted for the largest market share. This can be attributed to the rising adoption of pets among the masses to enjoy their companionship. Besides this, the increasing affordability of molecular diagnostic tests, making them a viable option for a wider range of veterinary practices, is contributing to the growth of the market.
  • Challenges and Opportunities: Challenges in veterinary molecular diagnostics include the need for cost-effective and user-friendly technologies, as well as the requirement for extensive validation to ensure accuracy across diverse animal species. Opportunities lie in the development of rapid, point-of-care assays for timely diagnosis and the potential for personalized treatment plans based on genetic information, advancing animal health care.

Veterinary Molecular Diagnostics Market Trends:

Growing Adoption of Pets Among the Masses

The growing adoption of pets among the masses is positively influencing the veterinary molecular diagnostics market. This surge in pet ownership is resulting in a higher demand for veterinary services, including diagnostics. For instance, according to the pet population data published in March 2021 by the Pet Food Manufacturers Association, over 59% of households in the United Kingdom had pets, with over 32.6 million pets in 2021. The trend of treating pets as family members is growing, which in turn is augmenting the veterinary molecular diagnostics market demand. Moreover, dogs and cats are the popular pets adopted by pet parents. For instance, the dog population was around 604.5 million in 2022, whereas the cat population was approx. 408.2 million globally. Besides this, the American Pet Products Association published in April 2022 that the total American pet industry expenditure reached US$ 123.6 Billion in 2021, up from US$ 103.6 Billion in 2020. The rise in animal health expenditure is expected to drive the growth of the veterinary molecular diagnostics market, as a significant portion of pet owners are expected to use advanced diagnostic modalities for various disease conditions in animals and propel the veterinary molecular diagnostics market's recent price.

Rising Prevalence of Animal Diseases

The rising prevalence of animal diseases is bolstering the growth of the veterinary molecular diagnostics market. According to a study published by the University of Calgary in June 2021, conducted to investigate the infections of Echinococcus multilocularis in domestic dogs to infer their potential role in zoonotic transmission, stated that Echinococcus multilocularis, a parasitic helminth of the northern hemisphere (Alberta, Canada), normally cycles through definitive and intermediate hosts. But in urban areas, domestic dogs can also become hosts for this parasite, which could become a significant risk factor to humans due to their proximity. Besides this, it is estimated that one in five farm animals is lost due to diseases each year, while many more animals suffer the effects of illness. According to an article published by Emerging Pathogen Institutes in November 2021, bovine respiratory diseases account for 75% of feedlot illnesses, and economic losses to cattle producers exceed US$ 1 Billion every year. The estimated costs for pinkeye are US$ 150 Million yearly, and losses to dairy producers due to foot rot range from US$ 120 to US$ 350 per animal. Such increasing losses and genetic disorders among animals are expected to drive the demand for veterinary molecular diagnostics, thereby augmenting the veterinary molecular diagnostics market share.

Increasing Advancements in Molecular Diagnostic Technologies

The increasing advancements in molecular diagnostic technologies are bolstering the growth of the market. Cutting-edge molecular diagnostic technologies, such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and microarray analysis, are continually evolving to provide veterinarians with unparalleled insights into the health of animals. Moreover, various key market players are launching improved diagnostics kits and instruments to facilitate quality diagnosis and treatments. For instance, in April 2022, Carolina Liquid Chemistries Corp of Greensboro signed a semi-exclusive agreement to distribute a portable analyzer for the US veterinary market. The company distributed the SeamatySMT-120 VP veterinary automated chemistry analyzer, a compact, fully automatic chemistry, electrolyte immunoassay, and coagulation analyzer for animal health diagnosis. Similarly, in September 2021, Micro Vet Diagnostics launched Micro-chem II, a completely new chemistry, electrolyte, immunoassay, and coagulation analyzer for animal health, producing accurate reference and laboratory-quality results. Such innovations are enhancing the efficiency of veterinary laboratories and enabling quicker turnaround times for test results, which is anticipated to propel veterinary molecular diagnostics market revenue in the coming years.

Global Veterinary Molecular Diagnostics Industry Segmentation:

Breakup by Product:

  • Kits and Reagents
  • Instruments
  • Software and Services

Kits and reagents dominate the market

The veterinary molecular diagnostics market report has provided a detailed breakup and analysis of the market based on the product. This includes kits and reagents, instruments, and software and services. According to the report, kits and reagents represented the largest segment.

In veterinary molecular diagnostics, various kits and reagents are required to conduct tests and experiments to detect and analyze nucleic acids from animal samples. These molecular diagnostic tools are used for a wide range of purposes, including disease detection, genotyping, pathogen identification, and genetic research in animals. Kits and reagents for next-generation sequencing (NGS) are employed to characterize the genomes of pathogens, aiding in the study of their evolution, drug resistance, and virulence factors. They also enable the study of epigenetic modifications in animal DNA, providing insights into gene regulation and potential links between epigenetic changes and disease susceptibility.

Breakup by Technology:

  • Real Time PCR
  • Microarray
  • DNA Sequencing

Real time PCR holds the largest share in the market

Real-time PCR (Polymerase Chain Reaction) in Veterinary Molecular Diagnostics is a molecular biology technique used to amplify and quantify DNA in real-time during the PCR process. It is a sensitive and accurate method for measuring the amount of a target DNA or RNA molecule in a biological sample. Real-time PCR is widely employed to examine and quantify pathogens in animals, including viruses, bacteria, fungi, and parasites. It also allows for early and accurate diagnosis, enabling prompt treatment and disease management.

Breakup by Animal Type:

  • Companion Animal
  • Livestock Animal

Companion animal holds the biggest share in the market

As per the veterinary molecular diagnostics market statistics by IMARC, the increasing trend of pet humanization is contributing to the growth of this segment. Companion animals, like dogs, cats, and other pets, require veterinary molecular diagnostics to detect diseases and health conditions. Some companion animals are prone to genetic disorders or inherited diseases. The rising pet ownership and growing consciousness of pet parents regarding the health of their pets are bolstering the market for molecular diagnostics. For instance, there are over 31 million pet dogs and around 2.44 million pet cats in India. The pet cat population may reach 4.89 million by 2026. 11% of people in India own at least four pets. Molecular diagnostics can identify genetic mutations or markers associated with these conditions, allowing breeders to make informed decisions about breeding and helping veterinarians manage the health of affected animals. Molecular tests can rapidly identify the presence of infectious agents, including viruses, bacteria, and parasites. This is crucial for diagnosing and managing diseases like parvovirus, feline leukemia, and Lyme disease.

Breakup by Disease Type:

  • Vector-borne Diseases
  • Respiratory Pathogens
  • Diarrhea Pathogens
  • Others

Vector-borne diseases hold the maximum share in the market

Vector-borne diseases in animals are infections that are transmitted from one animal to another through the bites of arthropod vectors, similar to how these diseases are transmitted to humans. They can have significant economic impacts on agriculture and can reduce the productivity of livestock, decrease meat and milk production, and even lead to animal deaths. Molecular diagnostic methods, like PCR, swiftly and precisely identify the genetic material of pathogens causing vector-borne diseases in animals, crucial for efficient disease control. Such techniques aid in tracking disease advancement in infected animals, enabling veterinarians to gauge infection severity and adapt treatment strategies accordingly.

Breakup by End User:

  • Veterinary Hospitals
  • Clinical Laboratories
  • Research Institutes

The veterinary molecular diagnostics market overview indicates that veterinary molecular diagnostics plays a crucial role in veterinary hospitals by offering advanced tools and techniques for the monitoring and treatment of diseases in animals. They can be used in biosecurity protocols to quickly identify and isolate infected animals, preventing the spread of contagious diseases within veterinary hospitals and breeding facilities.

Veterinary molecular diagnostics plays a pivotal role in clinical laboratories dedicated to animal healthcare. These sophisticated techniques harness the power of molecular biology to provide rapid, precise, and comprehensive insights into the health of animals. Besides this, in research institutes focused on enhancing understanding of animal health, genetics, and disease mechanisms, veterinary molecular diagnostics is essential. Utilizing state-of-the-art molecular methods like Polymerase Chain Reaction (PCR), DNA sequencing, and genotyping, these institutes conduct diverse studies benefiting both animal and human welfare.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest veterinary molecular diagnostics market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the rising adoption of pets among the masses to enjoy their companionship. For instance, according to pet ownership statistics by Forbes, pet ownership in the U.S. jumped significantly over the past three decades. As of 2024, 66% of U.S. households (86.9 million homes) own a pet. That is up from 56% in 1988. Moreover, the rise in the prevalence of animal diseases and injuries is also a major factor bolstering the market growth. According to the 2021-2022 National Pet Owners Survey conducted by the American Pet Products Association (APPA), the annual expenditure on a routine visit for dogs accounts for US$ 242 and US$ 178 for cats in the country. Furthermore, the increasing affordability of molecular diagnostic tests, making them a viable option for a wider range of veterinary practices, is contributing to the growth of the market. Apart from this, the escalating number of product launches in North America that focus on molecular diagnostics for animals drives the market growth. For instance, in January 2022, IDEXX Laboratories, Inc. expanded its reference laboratory menu of tests and services that will enable veterinarians to better meet the challenges of diagnosing and treating cancer. Such activities are expected to positively impact the veterinary molecular diagnostics market outlook in the coming years.

Competitive Landscape:

Key market players are developing innovative and more accurate diagnostic tests for animals by creating new assays, improving the sensitivity and specificity of existing tests, and expanding their test menu to cover a broader range of diseases. They are also expanding their product portfolios to include a wider range of diagnostic tests for different animal species, including companion animals (dogs and cats), livestock (cattle, pigs, and poultry), and exotic animals. Top companies are establishing partnerships or collaborations with distributors and veterinary clinics in different regions to reach a global customer base. They are also incorporating automation and advanced technologies into their diagnostic platforms to streamline testing processes, reduce turnaround times, and enhance the accuracy of results.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Biochek B.V.
  • bioMerieux SA
  • HealthGene Corporation
  • Heska Corporation
  • IDEXX Laboratories Inc.
  • INDICAL BIOSCIENCE GmbH
  • Ingenetix GmbH
  • NEOGEN Corporation
  • Qiagen N.V
  • Thermo Fisher Scientific Inc.
  • Veterinary Molecular Diagnostics Inc.
  • Zoetis Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global veterinary molecular diagnostics market in 2024?
  • 2.What is the expected growth rate of the global veterinary molecular diagnostics market during 2025-2033?
  • 3.What are the key factors driving the global veterinary molecular diagnostics market?
  • 4.What has been the impact of COVID-19 on the global veterinary molecular diagnostics market?
  • 5.What is the breakup of the global veterinary molecular diagnostics market based on the product?
  • 6.What is the breakup of the global veterinary molecular diagnostics market based on the technology?
  • 7.What is the breakup of the global veterinary molecular diagnostics market based on the animal type?
  • 8.What is the breakup of the global veterinary molecular diagnostics market based on the disease type?
  • 9.What are the key regions in the global veterinary molecular diagnostics market?
  • 10.Who are the key players/companies in the global veterinary molecular diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Veterinary Molecular Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Kits and Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Real Time PCR
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Microarray
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Animal Type

  • 8.1 Companion Animal
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Livestock Animal
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Disease Type

  • 9.1 Vector-borne Diseases
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Respiratory Pathogens
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diarrhea Pathogens
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Veterinary Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Clinical Laboratories
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Research Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Biochek B.V.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 bioMerieux SA
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 HealthGene Corporation
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Heska Corporation
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 IDEXX Laboratories Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 INDICAL BIOSCIENCE GmbH
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Ingenetix GmbH
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 NEOGEN Corporation
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Qiagen N.V
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Thermo Fisher Scientific Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Veterinary Molecular Diagnostics Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Zoetis Inc.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Veterinary Molecular Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Veterinary Molecular Diagnostics Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Veterinary Molecular Diagnostics Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Veterinary Molecular Diagnostics Market: Breakup by Animal Type (in %), 2024
  • Figure 7: Global: Veterinary Molecular Diagnostics Market: Breakup by Disease Type (in %), 2024
  • Figure 8: Global: Veterinary Molecular Diagnostics Market: Breakup by End User (in %), 2024
  • Figure 9: Global: Veterinary Molecular Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Veterinary Molecular Diagnostics (Kits and Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Veterinary Molecular Diagnostics (Kits and Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Veterinary Molecular Diagnostics (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Veterinary Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Veterinary Molecular Diagnostics (Software and Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Veterinary Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Veterinary Molecular Diagnostics (Real Time PCR) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Veterinary Molecular Diagnostics (Real Time PCR) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Veterinary Molecular Diagnostics (Microarray) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Veterinary Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Veterinary Molecular Diagnostics (DNA Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Veterinary Molecular Diagnostics (DNA Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Veterinary Molecular Diagnostics (Companion Animal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Veterinary Molecular Diagnostics (Companion Animal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Veterinary Molecular Diagnostics (Livestock Animal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Veterinary Molecular Diagnostics (Livestock Animal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Veterinary Molecular Diagnostics (Vector-borne Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Veterinary Molecular Diagnostics (Vector-borne Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Veterinary Molecular Diagnostics (Respiratory Pathogens) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Veterinary Molecular Diagnostics (Respiratory Pathogens) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Veterinary Molecular Diagnostics (Diarrhea Pathogens) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Veterinary Molecular Diagnostics (Diarrhea Pathogens) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Veterinary Molecular Diagnostics (Other Disease Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Veterinary Molecular Diagnostics (Other Disease Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Veterinary Molecular Diagnostics (Veterinary Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Veterinary Molecular Diagnostics (Veterinary Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Veterinary Molecular Diagnostics (Clinical Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Veterinary Molecular Diagnostics (Clinical Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Veterinary Molecular Diagnostics (Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Veterinary Molecular Diagnostics (Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: North America: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: North America: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: United States: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: United States: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Canada: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Canada: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Asia-Pacific: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Asia-Pacific: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: China: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: China: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Japan: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Japan: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: India: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: India: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: South Korea: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: South Korea: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Australia: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Australia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Indonesia: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Indonesia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Europe: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Europe: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Germany: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Germany: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: France: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: France: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: United Kingdom: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: United Kingdom: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Italy: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Italy: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Spain: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Spain: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Russia: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Russia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Latin America: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Latin America: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Brazil: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Brazil: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Mexico: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Mexico: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Middle East and Africa: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Middle East and Africa: Veterinary Molecular Diagnostics Market: Breakup by Country (in %), 2024
  • Figure 88: Middle East and Africa: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Global: Veterinary Molecular Diagnostics Industry: SWOT Analysis
  • Figure 90: Global: Veterinary Molecular Diagnostics Industry: Value Chain Analysis
  • Figure 91: Global: Veterinary Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Veterinary Molecular Diagnostics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Animal Type (in Million USD), 2025-2033
  • Table 5: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Disease Type (in Million USD), 2025-2033
  • Table 6: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 7: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Veterinary Molecular Diagnostics Market: Competitive Structure
  • Table 9: Global: Veterinary Molecular Diagnostics Market: Key Players